This is a StreetInsider.com Premium Only Page

Sunesis Pharmaceuticals (SNSS) –

Feb 25, 2021 06:09 PM Form 3 SUNESIS PHARMACEUTICALS For: Feb 24 Filed by: aMoon 2 Fund Limited Partnership

Feb 25, 2021 06:04 PM Form 3 SUNESIS PHARMACEUTICALS For: Feb 24 Filed by: Roshwalb Gur

Feb 24, 2021 08:11 PM Form 3 SUNESIS PHARMACEUTICALS For: Feb 24 Filed by: Chevallard Daniel R.

Feb 24, 2021 08:03 PM Form 3 SUNESIS PHARMACEUTICALS For: Feb 24 Filed by: DARCY THOMAS E

Feb 24, 2021 07:55 PM Form 3 SUNESIS PHARMACEUTICALS For: Feb 24 Filed by: Huang Michael

Feb 24, 2021 07:49 PM Form 3 SUNESIS PHARMACEUTICALS For: Feb 24 Filed by: Murphy Samuel Lafayette

Feb 24, 2021 07:45 PM Form 3 SUNESIS PHARMACEUTICALS For: Feb 24 Filed by: Pomerantz Roger

Feb 24, 2021 07:41 PM Form 3 SUNESIS PHARMACEUTICALS For: Feb 24 Filed by: Rojkjaer Lisa

Feb 24, 2021 07:32 PM Form 3 SUNESIS PHARMACEUTICALS For: Feb 24 Filed by: ROYSTON IVOR

Feb 24, 2021 04:38 PM Form 8-K SUNESIS PHARMACEUTICALS For: Feb 24

Feb 24, 2021 04:05 PM Viracta Therapeutics Announces Closing of Merger with Sunesis Pharmaceuticals and $65M Private Placement

Feb 23, 2021 06:04 AM Form 8-K SUNESIS PHARMACEUTICALS For: Feb 22

Feb 23, 2021 01:21 AM Oppenheimer Upgrades Sunesis Pharmaceuticals Inc. (SNSS) to Outperform

Feb 16, 2021 04:05 PM Form 425 SUNESIS PHARMACEUTICALS Filed by: SUNESIS PHARMACEUTICALS INC

Feb 16, 2021 03:51 PM Form SC 13G/A SUNESIS PHARMACEUTICALS Filed by: CAXTON CORP

Feb 16, 2021 11:07 AM Form SC 13G/A SUNESIS PHARMACEUTICALS Filed by: Ayrton Capital LLC

Feb 16, 2021 09:51 AM Form SC 13G/A SUNESIS PHARMACEUTICALS Filed by: CVI Investments, Inc.

Feb 16, 2021 08:02 AM Viracta Therapeutics Announces Notice of Allowance for U.S. Patent Application Covering the Use of its Combination Product Candidate for the Treatment of Epstein-Barr Virus-associated Lymphoma (SNSS)

Feb 16, 2021 08:00 AM Viracta Therapeutics Announces Notice of Allowance for U.S. Patent Application Covering the Use of its Combination Product Candidate for the Treatment of Epstein-Barr Virus-associated Lymphoma

Feb 16, 2021 06:43 AM Form SC 13G/A SUNESIS PHARMACEUTICALS Filed by: BIOTECHNOLOGY VALUE FUND L P

Feb 16, 2021 06:40 AM Form SC 13G/A SUNESIS PHARMACEUTICALS Filed by: Nantahala Capital Management, LLC

Feb 12, 2021 04:42 PM Form 425 SUNESIS PHARMACEUTICALS Filed by: SUNESIS PHARMACEUTICALS INC

Feb 12, 2021 04:35 PM Form 8-K SUNESIS PHARMACEUTICALS For: Feb 12

Feb 11, 2021 05:15 PM Form 425 SUNESIS PHARMACEUTICALS Filed by: SUNESIS PHARMACEUTICALS INC

Feb 11, 2021 04:05 PM Viracta Therapeutics to Participate in Upcoming Virtual Investor Conferences

Jan 15, 2021 06:24 AM Form EFFECT SUNESIS PHARMACEUTICALS

Jan 14, 2021 05:13 PM Form 424B3 SUNESIS PHARMACEUTICALS

Jan 13, 2021 06:03 AM Form S-4/A SUNESIS PHARMACEUTICALS

Jan 7, 2021 06:01 PM Form 3 SUNESIS PHARMACEUTICALS For: Jan 01 Filed by: Hyare Parvinder S

Jan 7, 2021 08:39 AM Form SC 13G/A SUNESIS PHARMACEUTICALS Filed by: SABBY MANAGEMENT, LLC

Jan 7, 2021 06:01 AM Form 425 SUNESIS PHARMACEUTICALS Filed by: SUNESIS PHARMACEUTICALS INC

Jan 4, 2021 12:35 PM Form SC 13G SUNESIS PHARMACEUTICALS Filed by: LYTTON LAURENCE W

Dec 22, 2020 06:29 AM Form 8-K SUNESIS PHARMACEUTICALS For: Dec 16

Dec 22, 2020 06:27 AM Form 425 SUNESIS PHARMACEUTICALS Filed by: SUNESIS PHARMACEUTICALS INC

Dec 22, 2020 06:25 AM Form S-4 SUNESIS PHARMACEUTICALS

Dec 7, 2020 08:35 AM Viracta Therapeutics Announces Presentation of Updated Phase 2 Data at ASH 2020 and Productive Outcome of its Recent End of Phase 2 Meeting with the FDA (SNSS)

Dec 7, 2020 08:30 AM Viracta Therapeutics Announces Presentation of Updated Phase 2 Data at ASH 2020 and Productive Outcome of its Recent End of Phase 2 Meeting with the FDA

Dec 7, 2020 06:20 AM Form 425 SUNESIS PHARMACEUTICALS Filed by: SUNESIS PHARMACEUTICALS INC

Nov 30, 2020 04:58 PM SUNESIS ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of SNSS and Encourages Investors to Contact the Firm

Nov 30, 2020 08:03 AM Form 8-K SUNESIS PHARMACEUTICALS For: Nov 29

Nov 30, 2020 08:01 AM Form 425 SUNESIS PHARMACEUTICALS Filed by: SUNESIS PHARMACEUTICALS INC

Nov 30, 2020 07:32 AM Sunesis Pharmaceuticals (SNSS) and Viracta Therapeutics to Merge in All-Stock Transaction

Nov 30, 2020 07:30 AM Sunesis Pharmaceuticals and Viracta Therapeutics Announce Definitive Merger Agreement

Nov 16, 2020 04:34 PM Form 10-Q SUNESIS PHARMACEUTICALS For: Sep 30

Nov 16, 2020 04:17 PM Form 8-K SUNESIS PHARMACEUTICALS For: Nov 16

Nov 16, 2020 04:05 PM Sunesis Pharmaceuticals Reports Third Quarter 2020 Financial Results and Recent Highlights

Nov 9, 2020 07:00 AM Sunesis Pharmaceuticals to Host Conference Call on November 16th to Discuss Third Quarter 2020 Financial Results and Recent Highlights

Oct 12, 2020 07:00 AM Sunesis Pharmaceuticals Announces Presentation of SNS-510 Preclinical Data at the 32nd EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

Sep 18, 2020 04:14 PM Form 8-K SUNESIS PHARMACEUTICALS For: Sep 18

Sep 3, 2020 07:00 AM Sunesis Pharmaceuticals Announces Participation at Upcoming Investor Conferences